Expression Table for this CRE
| CNhs14498 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2 | 1632.7 |
| CNhs12060 | Skeletal Muscle Cells, donor6 | 22.2 |
| CNhs12052 | Fibroblast - Dermal, donor4 | 20.2 |
| CNhs14489 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2 | 17.5 |
| CNhs14496 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3 | 15.8 |
| CNhs12663 | MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2 | 15.3 |
| CNhs14492 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2 | 13.6 |
| CNhs12664 | MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 12.7 |
| CNhs12229 | pituitary gland, adult, donor10252 | 11.6 |
| CNhs12061 | Fibroblast - Cardiac, donor6 | 10.5 |
| CNhs12657 | MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2 | 9.9 |
| CNhs14501 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2 | 8.4 |
| CNhs12659 | MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2 | 8.3 |
| CNhs14518 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3 | 8.0 |
| CNhs11725 | argyrophil small cell carcinoma cell line:TC-YIK | 7.8 |
| CNhs13434 | mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1 | 7.3 |
| CNhs12656 | MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2 | 7.2 |
| CNhs12662 | MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2 | 6.9 |
| CNhs14491 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1 | 6.8 |
| CNhs13841 | iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2 | 6.5 |
| CNhs12666 | MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2 | 6.5 |
| CNhs14078 | amygdala, newborn, donor10223 | 6.3 |
| CNhs13844 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 6.2 |
| CNhs12660 | MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2 | 6.2 |
| CNhs11718 | mesenchymal stem cell line:Hu5/E18 | 5.9 |
| CNhs14488 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1 | 5.8 |
| CNhs12654 | MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2 | 5.8 |
| CNhs12655 | MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2 | 5.3 |
| CNhs13843 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2 | 5.2 |
| CNhs12045 | Smooth Muscle Cells - Coronary Artery, donor3 | 5.2 |
| CNhs12658 | MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2 | 5.1 |
| CNhs12064 | Anulus Pulposus Cell, donor2 | 5.1 |
| LShi10030_ACAGTG-CACTATG | Human induced pluripotent stem cells grown on feeder-free condition, biol_rep3 | 5.0 |
| CNhs12954 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2) | 4.7 |
| CNhs11680 | lung, fetal, donor1 | 4.6 |
| CNhs12642 | Bronchial Epithelial Cell, donor7 | 4.2 |
| CNhs11717 | oral squamous cell carcinoma cell line:HSC-3 | 4.1 |
| CNhs12665 | MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2 | 4.1 |
| CNhs14573 | Myoblast differentiation to myotubes, day06, control donor2 | 3.7 |
| CNhs12953 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15) | 3.3 |
| CNhs14519 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1 | 3.2 |
| CNhs11722 | leiomyoma cell line:10964C | 3.1 |
| LShi10030_ACTTGA-CACTAGT | Human induced pluripotent stem cells grown on feeder-free condition, biol_rep2 | 3.0 |
| CNhs11714 | chronic lymphocytic leukemia (T-CLL) cell line:SKW-3 | 3.0 |
| CNhs12998 | testis, adult, pool2 | 3.0 |
| CNhs11371 | Adipocyte - subcutaneous, donor2 | 2.9 |
| CNhs12075 | Hepatic Sinusoidal Endothelial Cells, donor1 | 2.9 |
| CNhs12684 | K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2 | 2.7 |
| CNhs11723 | leiomyoma cell line:15242A | 2.5 |
| CNhs12317 | parietal lobe, adult, donor10252 | 2.5 |